Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase 2”

40,138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40,138 results

Testing effectiveness (Phase 2)Looking for participantsNCT07080567
What this trial is testing

Manipulating the Peri-Infarct Area Using Maraviroc to Enhance Motor Skills After Stroke

Who this might be right for
Ischemic StrokeStrokeStroke Acute
Emmanuel Carrera 80
Testing effectiveness (Phase 2)Study completedNCT01797900
What this trial is testing

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Who this might be right for
Nasopharyngeal Neoplasms
Chinese Academy of Medical Sciences 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621707
What this trial is testing

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

Who this might be right for
Esophageal Squamous Cell CarcinomasConcurrent ChemoradiotherapyImmunotherapy+1 more
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT04349436
What this trial is testing

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune Inc. 65
Post-approval studies (Phase 4)Study completedNCT02932436
What this trial is testing

Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2Diastolic Dysfunction
Johannes Gutenberg University Mainz 144
Testing effectiveness (Phase 2)UnknownNCT03848611
What this trial is testing

CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-small Cell Lung Cancer
AnewPharma 20
Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Testing effectiveness (Phase 2)Looking for participantsNCT06383533
What this trial is testing

Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma

Who this might be right for
Bile Duct Adenocarcinoma Non-ResectableHER2 Gene Mutation
Zhejiang Cancer Hospital 28
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)UnknownNCT05969158
What this trial is testing

Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Sun Yat-sen University 90
Testing effectiveness (Phase 2)Ended earlyNCT01533948
What this trial is testing

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10
Testing effectiveness (Phase 2)UnknownNCT01364155
What this trial is testing

Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR

Who this might be right for
Impaired Glucose ToleranceInsulin Resistance
Limerick BioPharma 50
Testing effectiveness (Phase 2)WithdrawnNCT06557278
What this trial is testing

Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Mirror Biologics, Inc.
Testing effectiveness (Phase 2)Study completedNCT06259526
What this trial is testing

The Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Who this might be right for
Depression
Tasly Pharmaceutical Group Co., Ltd 267
Not applicableStudy completedNCT00222885
What this trial is testing

Multi-Tracer PET Quantitation of Insulin Action in Muscle (Phase 1, Phase 2, Phase 3, Phase 4)

Who this might be right for
DiabetesObesity
University of Pittsburgh 50
Testing effectiveness (Phase 2)Looking for participantsNCT05207085
What this trial is testing

Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults

Who this might be right for
Trichotillomania (Hair-Pulling Disorder)
Yale University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585
What this trial is testing

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
BTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma
Li Zhiming 128
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Testing effectiveness (Phase 2)Ended earlyNCT00417885
What this trial is testing

A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 6
Load More Results